1. Home
  2. Analysis
  3. Braftovi
  4. Valacyclovir

Braftovi and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Braftovi (encorafenib) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include loss of consciousness among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Braftovi and Valacyclovir. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Braftovi?

Braftovi has active ingredients of encorafenib. eHealthMe is studying from 7,609 Braftovi users. Check the latest studies of Braftovi.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.

On Jul, 16, 2026

19 people who take Braftovi and Valacyclovir together, and have interactions are studied.

Braftovi and Valacyclovir drug interactions.

What are the common drug interactions of Braftovi and Valacyclovir, by gender? *:

female:

  1. Loss of consciousness
  2. Pain
  3. Death
  4. Arthralgia (joint pain)
  5. Dry skin
  6. Spleen disorder (disease of spleen)
  7. Confusional state

male:

  1. Disease progression
  2. Confusional state
  3. Fatigue (feeling of tiredness)
  4. Hospitalisation
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

What are the common drug interactions of Braftovi and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Disease progression

50-59:

  1. Disease progression
  2. Arthralgia (joint pain)
  3. Dry skin
  4. Spleen disorder (disease of spleen)

60+:

  1. Confusional state
  2. Death
  3. Hospitalisation
  4. Fatigue (feeling of tiredness)
  5. Loss of consciousness
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Pain

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 9 people, 47.37%
  2. Colon Cancer: 5 people, 26.32%
  3. Multiple Myeloma (cancer of the plasma cells): 1 person, 5.26%
  4. Brain Neoplasm Malignant (brain cancer tumour): 1 person, 5.26%
  5. Brain Neoplasm (tumour of brain): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Braftovi and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Braftovi and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Braftovi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Braftovi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on encorafenib and valacyclovir hydrochloride (the active ingredients of Braftovi and Valacyclovir, respectively), and Braftovi and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.